Pharma megamergers need to go under a microscope, Senators tell FTC

18th September 2019 Uncategorised 0

Big M&A has returned to pharma smack in the middle of a fierce drug pricing debate—and a group of senators is urging the FTC to weigh those deals accordingly. Of particular interest? AbbVie’s proposed Allergan buyout and Bristol-Myers Squibb’s Celgene merger.

More: Pharma megamergers need to go under a microscope, Senators tell FTC
Source: fierce